Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”

老虎资讯综合

02/09

周一，Hims & Hers Health Inc. 发表声明：诺和诺德的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。

声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。

诺和诺德当天早些时候宣布，已就Hims & Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。

截至发稿，Hims & Hers Health的盘前跌幅扩大至超22%。

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1168115277"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168115277\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168115277?lang=zh_CN&edition=fundamental","thumbnail":"https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955","is_english":false,"pubTime":"2026-02-09 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168115277","market":"us","top_or_hot":-1,"title":"Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”","media":"老虎资讯综合","content":"<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 发表声明： <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。</p><p>声明称，Hims &amp; Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。</p><p>诺和诺德当天早些时候宣布，已就Hims &amp; Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。</p><p>截至发稿，Hims &amp; Hers Health的盘前跌幅扩大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health：诺和诺德的诉讼是一种“公然的攻击”\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-02-09 21:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 发表声明： <a href=\"https://laohu8.com/S/NVO\">诺和诺德</a> 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。</p><p>声明称，Hims &amp; Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。</p><p>诺和诺德当天早些时候宣布，已就Hims &amp; Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。</p><p>截至发稿，Hims &amp; Hers Health的盘前跌幅扩大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMY","symbol_name":"Defiance Leveraged Long + Income HIMS ETF","start_time":0,"source_url":"","article_id":"1168115277","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168115277","pubTimestamp":1770645283,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"将继续奋战以保障选择权、可负担性及可及性。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HIMY":"Defiance Leveraged Long + Income HIMS ETF","HIMS":"Hims & Hers Health Inc.","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","NVO":"诺和诺德"},"translate_title":"Hims & Hers Health: Novo Nordisk's lawsuit is a'blatant attack '","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/05b50cd6815471913b42a5e11bf6d71b","symbols_score_info":{"HIMS":2,"HMYY":1,"HIMY":1,"HIMZ":1,"NVO":2},"content_text":"周一，Hims & Hers Health Inc. 发表声明： 诺和诺德 的诉讼是对数百万依赖复方药获得个性化治疗的美国民众公然的攻击，大型制药企业再次将美国司法体系武器化以限制消费者选择。声明称，Hims & Hers Health长期为数百万美国人提供安全获取个性化医疗服务的渠道，将继续奋战以保障选择权、可负担性及可及性。诺和诺德当天早些时候宣布，已就Hims & Hers Health在美国市场销售的复方司美格鲁肽产品侵犯专利提起诉讼。截至发稿，Hims & Hers Health的盘前跌幅扩大至超22%。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}